Medigene to Present at Upcoming Scientific Conferences

Barchart · 10/16 04:30

Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, will present at the 16th Annual Protein & Antibody Engineering Summit (PEGS) to be held from November 5-7, 2024 in Barcelona as well as at the Cell 2024 conference by Oxford Global from November 6-8, 2024 in London. In addition, two posters will be presented at the 39th Society for Immunotherapy of Cancer (SITC) from November 6-10, 2024, in Houston, TX, USA.

Read more at globenewswire.com